IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
This Quarter Return
+14.97%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
–
AUM
$493M
AUM Growth
+$493M
(+1.3%)
Cap. Flow
-$15.6M
Cap. Flow
% of AUM
-3.17%
Top 10 Holdings %
Top 10 Hldgs %
33.64%
Holding
86
New
21
Increased
22
Reduced
21
Closed
22
Top Buys
| 1 |
Baxter International
BAX
|
$16.2M |
| 2 |
Boston Scientific
BSX
|
$13.6M |
| 3 |
Biogen
BIIB
|
$13.4M |
| 4 |
Cardinal Health
CAH
|
$13.3M |
| 5 |
Neurocrine Biosciences
NBIX
|
$9.56M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$15.5M |
| 2 |
AstraZeneca
AZN
|
$15.5M |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$14.2M |
| 4 |
Elevance Health
ELV
|
$12.6M |
| 5 |
DexCom
DXCM
|
$12.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Danaher
DHR
$143B
| $7.75M | 1.51% |
+30,000
| New | +$7.75M |
|
27
UnitedHealth
UNH
$279B
| $7.58M | 1.47% |
+15,000
| New | +$7.58M |
|
28
Inspire Medical Systems
INSP
$2.53B
| $7.1M | 1.38% |
+40,000
| New | +$7.1M |
|
29
Intellia Therapeutics
NTLA
$1.26B
| $7M | 1.36% |
125,000
+41,505
| +50% | +$2.32M |
|
30
Kura Oncology
KURA
$732M
| $6.83M | 1.33% |
500,000
+38,690
| +8% | +$529K |
|
|
ISEE
31
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $6.73M | 1.31% |
+375,000
| New | +$6.73M |
|
32
Tenet Healthcare
THC
$16.5B
| $6.71M | 1.3% |
130,000
-120,485
| -48% | -$6.21M |
|
33
Krystal Biotech
KRYS
$4.35B
| $6.27M | 1.22% |
90,000
+37,816
| +72% | +$2.64M |
|
34
iRhythm Technologies
IRTC
$5.67B
| $6.26M | 1.22% |
50,000
-7,403
| -13% | -$927K |
|
35
DaVita
DVA
$9.72B
| $6.21M | 1.21% |
75,000
+22,816
| +44% | +$1.89M |
|
|
BPMC
36
DELISTED
Blueprint Medicines
BPMC
| $6.13M | 1.19% |
93,000
-37,000
| -28% | -$2.44M |
|
37
Insulet
PODD
$24.2B
| $5.74M | 1.11% |
+25,000
| New | +$5.74M |
|
38
Illumina
ILMN
$15.2B
| $5.72M | 1.11% |
+30,000
| New | +$5.72M |
|
39
Aclaris Therapeutics
ACRS
$223M
| $5.35M | 1.04% |
340,000
+54,029
| +19% | +$850K |
|
|
MRTX
40
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.89M | 0.95% |
+70,000
| New | +$4.89M |
|
41
Exact Sciences
EXAS
$9.33B
| $4.87M | 0.95% |
+150,000
| New | +$4.87M |
|
42
Apellis Pharmaceuticals
APLS
$3.51B
| $4.78M | 0.93% |
70,000
-29,150
| -29% | -$1.99M |
|
|
NVRO
43
DELISTED
NEVRO CORP.
NVRO
| $4.66M | 0.91% |
100,000
+21,723
| +28% | +$1.01M |
|
44
Alkermes
ALKS
$4.95B
| $4.47M | 0.87% |
200,000
-61,966
| -24% | -$1.38M |
|
|
RVNC
45
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.05M | 0.79% |
+150,000
| New | +$4.05M |
|
|
ITOS
46
DELISTED
iTeos Therapeutics
ITOS
| $3.72M | 0.72% |
195,000
+38,447
| +25% | +$732K |
|
47
Gossamer Bio
GOSS
$587M
| $3.59M | 0.7% |
+300,000
| New | +$3.59M |
|
48
Denali Therapeutics
DNLI
$2.24B
| $3.53M | 0.69% |
+115,000
| New | +$3.53M |
|
49
SI-BONE Inc
SIBN
$700M
| $3.49M | 0.68% |
200,000
+42,683
| +27% | +$745K |
|
50
Ventyx Biosciences
VTYX
$184M
| $3.49M | 0.68% |
+100,000
| New | +$3.49M |
|